TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding June 24, 1994